Combination of Novel Therapies for CKD Comorbid Depression
Public ClinicalTrials.gov record NCT04422652. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Combination of Novel Therapies for CKD Comorbid Depression (CONCORD)
Study identification
- NCT ID
- NCT04422652
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Stony Brook University
- Other
- Enrollment
- 201 participants
Conditions and interventions
Interventions
- Bupropion Drug
- Behavioral activation therapy Behavioral
- Placebo Drug
- Clinical Management Other
Drug · Behavioral · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 23, 2020
- Primary completion
- Mar 31, 2027
- Completion
- Mar 31, 2027
- Last update posted
- Nov 27, 2025
2020 – 2027
United States locations
- U.S. sites
- 4
- U.S. states
- 3
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Stony Brook University Medical Center | Stony Brook | New York | 11794-8430 | Not yet recruiting |
| Parkland Health and Hospital System | Dallas | Texas | 75235 | Recruiting |
| UT Southwestern and Affiliates | Dallas | Texas | 75390 | Recruiting |
| University of Washington | Seattle | Washington | 98195 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04422652, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 27, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04422652 live on ClinicalTrials.gov.